PCA
BIVV

Providence Capital Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Providence Capital Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 320
2017
Q4 		$0 Buy
+2
New +$109 ﹤0.01% 311

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Providence Capital Advisors's BIVV Position: Q1 2018 in Review

Providence Capital Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2 shares.

Providence Capital Advisors first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Providence Capital Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Providence Capital Advisors sold 2 Bioverativ Inc. Common Stock shares in Q1 2018.
  • Providence Capital Advisors first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Providence Capital Advisors's Bioverativ Inc. Common Stock position peaked at $0 in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Providence Capital Advisors's 13F filing for Q1 2018, filed 10 May 2018.